Patents/Assignees

XEQUEL BIO, Inc.

2 patents in portfolio

US12138293utility2024
Peptide Formulations and Ophthalmic Uses Thereof
0 cites
US12128086utility2024
Formulations and Methods of Use for Alpha Connexin C-terminal (ACT) Peptides
0 cites